Compugen (CGEN) Revenue (QoQ) (2009 - 2026)
Powered by 
Analysis
Compugen (CGEN) Revenue (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Compugen | 241.50 Mn | 155.89 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.58% |
| Mar 31, 2026 | -96.77% |
| Dec 31, 2025 | 3,460.66% |
| Sep 30, 2025 | 50.44% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | 55.27% |
| Dec 31, 2024 | -91.41% |
| Sep 30, 2024 | 155.63% |
| Jun 30, 2024 | 161.90% |
| Dec 31, 2016 | -24.29% |
| Sep 30, 2016 | -85.89% |
| Jun 30, 2016 | 433.33% |
| Mar 31, 2016 | -98.88% |
| Dec 31, 2015 | 3,530.13% |
| Sep 30, 2015 | 2.69% |
| Jun 30, 2015 | -56.53% |
| Mar 31, 2015 | -92.17% |
| Dec 31, 2014 | 281.37% |
| Sep 30, 2014 | -12.53% |
| Jun 30, 2014 | -7.92% |